交易中 09-19 12:01:47 美东时间
+0.082
+4.24%
PharmaCyte Biotech (NASDAQ:PMCB) announced a $7 million investment in MyMD Pharmaceuticals (NASDAQ:MYMD), a clinical stage biopharmaceutical company committed to developing novel therapies for age-rel...
05-21 21:16
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder valuePharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company") announces it has made
2023-11-15 21:34
Femasys Secures $6.85M Additional Financing With Strategic Investment From Inve...
2023-11-15 08:32
Company prepares for comprehensive discussion with FDA to determine appropriate next steps for technology while evaluating additional opportunitiesPharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company")
2023-10-31 21:22
On Tuesday, 386 stocks made new 52-week lows.
2023-09-27 00:04
Cortexyme (NASDAQ:CRTX – Get Rating) and PharmaCyte Biotech (OTCMKTS:PMCB – Get...
2023-04-13 04:42
PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Rating) shares traded up 0.4% on Tu...
2023-03-31 04:02
PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Rating)'s stock price traded up 0.4...
2023-03-29 14:04
PharmaCyte Biotech (OTCMKTS:PMCBD – Get Rating) and Vericel (NASDAQ:VCEL – Get ...
2023-03-10 14:25
PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Rating) shares shot up 0.7% during ...
2023-01-18 14:52